CAS-One planning and navigation technology sets the standard in image-guided interventional and surgical treatments for the liver, and is poised to become the standard-of-care. Clinical benefits of CAS-One technology include improved accuracy, decreased radiation exposure for patient and operator and a reduction in total procedure time. Nevertheless, confronted by an aging population, rise in chronic diseases including cancer, and increasing demands from healthcare consumers, the healthcare system is under pressure, and to be adopted into routine clinical practice, new technologies must provide economic value to healthcare providers and institutions. CAS-One rises to the challenge on both counts – as well as helping to improve patient outcomes, the system is designed to produce efficiency gains for institutions.
CAS-One is clinically proven to reduce procedure time in percutaneous interventions by 47% versus conventional procedures (Beyer et al 2016), freeing up valuable nurse and physician time.
Not only are CAS-One procedures shorter than conventional treatment, the procedure length is highly predictable, even with complex cases. This means that more patients can be scheduled into a day in the OR or IR suite for this or other procedures, thereby increasing efficiency and reducing waiting times.
The internet and rise of social media has revolutionised society’s access to information and has irrevocably altered decision-making processes in many areas of our lives. In healthcare, this has had a profound effect on patients’ ability to research and select where they believe they will get the best possible medical treatment. By offering the latest technologies and therapy options, healthcare institutions are uniquely positioned to attract new patients and to establish themselves as innovation leaders in healthcare provision.